rs1042522
|
|
Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
550 samples (275 cases/275 control) of peripheral blood obtained from women (aged 22-87 years) with breast cancer and from healthy women (aged 23-87 years) were genotyped for frequencies of the following gene variances: R72P/rs1042522 (gene TP53) and S31R/ss4388499 (gene p21).
|
20127253 |
2010 |
rs1042522
|
|
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
550 samples (275 cases/275 control) of peripheral blood obtained from women (aged 22-87 years) with breast cancer and from healthy women (aged 23-87 years) were genotyped for frequencies of the following gene variances: R72P/rs1042522 (gene TP53) and S31R/ss4388499 (gene p21).
|
20127253 |
2010 |
rs1042522
|
|
Adenocarcinoma of prostate
|
|
0.010 |
GeneticVariation
|
BEFREE |
Prostate adenocarcinoma is one of the leading causes of cancer related mortality in men but still limited knowledge is available about its associated functional SNPs including rs1042522 (Pro72Arg).
|
24935583 |
2014 |
rs1042522
|
|
Endometriosis
|
|
0.060 |
GeneticVariation
|
BEFREE |
Arg72Pro p53 polymorphism in Italian women: no association with endometriosis.
|
17412337 |
2007 |
rs1042522
|
|
Ulcerative Colitis
|
|
0.030 |
GeneticVariation
|
BEFREE |
Our data suggest that R72P variant seems to be associated with high risk for development of CRC but carries low risk for development of UC.
|
20309662 |
2010 |
rs1042522
|
|
Primary malignant neoplasm
|
|
0.100 |
GeneticVariation
|
BEFREE |
Arg72Pro SNP of p53 has been associated with many types of cancer as well as with survival and longevity.
|
22116280 |
2011 |
rs1042522
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Arg72Pro SNP of p53 has been associated with many types of cancer as well as with survival and longevity.
|
22116280 |
2011 |
rs1042522
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
R72P associations with specific cancer risk, particularly hematological malignancies, have been conflicting.
|
25768405 |
2015 |
rs1042522
|
|
Primary malignant neoplasm
|
|
0.100 |
GeneticVariation
|
BEFREE |
R72P associations with specific cancer risk, particularly hematological malignancies, have been conflicting.
|
25768405 |
2015 |
rs1042522
|
|
Hematologic Neoplasms
|
|
0.020 |
GeneticVariation
|
BEFREE |
R72P associations with specific cancer risk, particularly hematological malignancies, have been conflicting.
|
25768405 |
2015 |
rs1042522
|
|
Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
Arg72Pro and PIN3(16bp duplication) polymorphisms are proposed to have an effective role in structural changes of p53 and have therefore attracted interest as a risk factor for breast cancer in different populations.
|
25854391 |
2015 |
rs1042522
|
|
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
Arg72Pro and PIN3(16bp duplication) polymorphisms are proposed to have an effective role in structural changes of p53 and have therefore attracted interest as a risk factor for breast cancer in different populations.
|
25854391 |
2015 |
rs1042522
|
|
Li-Fraumeni Syndrome
|
|
0.040 |
GeneticVariation
|
BEFREE |
A common single nucleotide repeat (snp) in exon 3 (rs1042522) and deletion sequencing chromatograms in exon 4 were examined in combination to estimate LOH in both LFS tubes and advanced serous carcinomas from the general population.
|
19834951 |
2010 |
rs1042522
|
|
Carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
A common single nucleotide repeat (snp) in exon 3 (rs1042522) and deletion sequencing chromatograms in exon 4 were examined in combination to estimate LOH in both LFS tubes and advanced serous carcinomas from the general population.
|
19834951 |
2010 |
rs1042522
|
|
Primary malignant neoplasm
|
|
0.100 |
GeneticVariation
|
BEFREE |
A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers.
|
16419081 |
2006 |
rs1042522
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers.
|
16419081 |
2006 |
rs1042522
|
|
Malignant tumor of cervix
|
|
0.100 |
GeneticVariation
|
BEFREE |
A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors.
|
25181402 |
2015 |
rs1042522
|
|
Cervix carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors.
|
25181402 |
2015 |
rs1042522
|
|
cervical cancer
|
|
0.100 |
GeneticVariation
|
BEFREE |
A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors.
|
25181402 |
2015 |
rs1042522
|
|
Down Syndrome
|
|
0.020 |
GeneticVariation
|
BEFREE |
A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers.
|
27852141 |
2017 |
rs1042522
|
|
Complete Trisomy 21 Syndrome
|
|
0.020 |
GeneticVariation
|
BEFREE |
A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers.
|
27852141 |
2017 |
rs1042522
|
|
Steroid Sulfatase Deficiency Disease
|
|
0.010 |
GeneticVariation
|
BEFREE |
A series of 100 STS were genotyped for the p53 Arg72Pro polymorphism using polymerase chain reaction.
|
19065769 |
2008 |
rs1042522
|
|
Ichthyosis, X-Linked
|
|
0.010 |
GeneticVariation
|
BEFREE |
A series of 100 STS were genotyped for the p53 Arg72Pro polymorphism using polymerase chain reaction.
|
19065769 |
2008 |
rs1042522
|
|
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
A significant association was found between TP53Arg72Pro (rs1042522) and CDH1 -160 C/A (rs16260) polymorphisms and breast cancer risk.
|
26666818 |
2016 |
rs1042522
|
|
Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
A significant association was found between TP53Arg72Pro (rs1042522) and CDH1 -160 C/A (rs16260) polymorphisms and breast cancer risk.
|
26666818 |
2016 |